DEF 14AThe Ballot
Taysha Gene Therapies, Inc. files DEF 14A
Filed Apr 22, 2026 · 2mo ago · Accession 0001193125-26-168525
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Taysha Gene Therapies, Inc.
- Ticker
- TSHA
- CIK
- 1806310
- Form type
- DEF 14A
- Filing date
- Apr 22, 2026
- Report date
- Jun 1, 2026
- Document
- d94391ddef14a.htm
- Size
- 2.7 MB